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Atrial Defibrillation Using a Unipolar, Single lead
Right Ventricular to Pectoral Can System
Jeanne E. Poole. Peter J. Kudenchuk, G. Lee Dolack. Gregory K. Jones, Marye
J. Gleva. Merritt H. Raitt. George Johnson, Rahul Mehra. Luc Mongeon. Gust
H. Bardy. University of Washington, Seattle, WA
Background; The active can, unipolar right ventricular(RV)single lead system
has been shown to be very effective for ventricular defibrillation using an RV+
..... CAN- biphasic pulsing configuration. If this same RV+ ..... CAN- unipo-
lar system could perform double-duty, providing atrial as well as ventricular
defibrillation, it would broaden the role of current implantable cardioverter-
defibrillators (ICDs). It would provide an atriallCD without multiple shock elec-
trodes, simultaneously providing backup protection for inadvertent induction
of ventricular fibrillation (VF) following atrial defibrillation.
Methods and Results; The pu rpose of this study was to determ ine the RV+
..... CAN- atrial defibrillation threshold at the time of ICD surgery for 10 VTNF
patients using the Medtronic 7219C ICD shell with a biphasic 65% tilt, 60 IlF
capacitance pulse delivered one minute following induction of AI' Initial pulse
strength was 100 V and was incremented in 100 V steps every minute if atrial
fibrillation persisted. The atrial defibrillation threshold data with the RV+ .....
CAN- system were 8.3 ± 4.1 joules, 511 ± 128 volts, and 58 ± 8 ohms.
Conclusions,' Although the RV+ ..... CAN- lead system does not provide
atrial defibrillation at energies likely to be painless (e.g., <0.2J), the safety
and simplicity of this system has advantages that must be considered when
compared to more complicated two and three lead elegtrode systems. If de-
tection algorithms for AF, using near and far field electrogram analysis prove
accurate, such a simple lead system may prove c1inicallyviable.
Is Coronary Revascularization Complete Therapy
for Secondary Prevention of Ischemic Cardiac
Arrest?
Emile G. Daoud. Mark Niebauer, William H. Kou, K. Ching Man. Theresa Davidson.
Laura Horwood. Fred Morady, S. Adam Strickberger. Veterans Affairs Medical
Center, and University ofMichigan Hospital, Ann Arbor, MI
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Effects of Digoxin on Ventricular Vulnerability
During Atrial Defibrillation via Implanted
Transvenous Catheter Electrodes in the Sterile
Pericarditis Model
Shinichi Niwano. Mary C. Sokoloski. Gregory M. Ayers, Albert L. Waldo. Case
Western ReseNe University. Cleveland. OH
digoxin
Objectives Because digoxin is often used in patients with atrial fibrillation. we
evaluated its effects on the relative risk of inducing ventricular tachyarrhyth-
mia (VTNF) during synchronized atrial defibrillation shocks delivered through
implanted transvenous catheter electrodes.
Methods. Sterile pericarditis was created in 10 mongrel dogs. Two catheter
electrodes with a 6 cm coil tip were inserted through the right external jugular
vein and placed in the distal coronary sinus and in the right atrial appendage.
To systematically achieve variable preceding ventricular coupling intervals
(VCls). the ventricles were paced during sinus rhythm before delivery of the
atrial shock in two protocols: 1) rapid pacing (8 stimuli, S1 S, protocol); and
21 double extra stimuli (long-short intervalsl following 8 basic stimuli (S, S2S3
protocol). The VCI (S, S1 or S2S3)was shortened by 10 ms until the ventricular
effective refractory period was achieved. After sensing the last paced ventric-
ular beat. an atrial shock was delivered with a 2 ms delay at a shock intensity
of 300 V (3.2-3.6 J). i.e.. maximum shock intensity ofthe device. Atrial shocks
were delivered 4 times at each VCI in each protocol. VCI was normalized by
subtracting the OT interval in the surface ECG from the actual VCI. The rela-
tionship between the VCI and induction of VTNF was evaluated in the drug
free state and after administration of a therapeutic (50 Ilg!kg. 5 dogs) or toxic
(to obtain toxic arrhythmia. 5 dogs) dose of digoxin.
Results. Data are shown in mean ± SD. for each protocol (S, S, or S1 S2S3).
To calculate a 99% probability of sinus rhythm (SR) after an atrial shock.logis-
tic regression was used. No significant difference was observed before and
after digoxin administration. The longest VCI that preceded VTNF induction
was OT + 50 ms (290 ms) before digoxin and OT + 50 ms (310 ms) after
digoxin.
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Conclusions. Digoxin did not significantly change the risk of VTNF induc-
tion during atrial defibrillation shocks delivered through transvenous catheter
electrodes at maximum shock intensity. Shocks delivered at VCls longer than
310 ms resulted in no VTNF induction.
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Noninvasive Predictors of Successful
Implantation of Transvenous Defibrillator lead
Systems
Erica D. Engelstein. Rebecca 1. Hahn, Kenneth M. Stein. Bruce 8. Lerman. New
York Hospital-Cornell University Medical Center, New York, NY
Successful implantation of transvenous defibrillator lead systems depends
on achieving an intraoperative defibrillation threshold (DFT) of ::s25 J. Since
defibrillation is related to a critical mass of myocardium, we sought to deter-
mine whether left ventricularlLV) mass or LV volume could predict successful
*p value> 0.05
No clinical characteristic was statistically different between patients with
and without ICD shocks. In conclusion, coronary revascularization alone may
be inadequate therapy for survivors of sudden cardiac arrest associated with
ischemia who are noninducible with programmed stimulation, and clinical
variables cannot predict which patients are likely to experience recurrent ma-
lignant ventricular arrhythmias. Therefore, ICD therapy should be considered
in these patients.
Clinical Characteristics:
Coronary revascularization has been suggested assole therapy for secondary
prevention of sudden cardiac arrest associated with ischemia. Among 412
consecutive patients receiving an implantable defibrillator (ICD), 23 (6%)
were identified as: sudden cardiac arrest survivors, noninducible with pro-
grammed stimulation, unstable angina or ischemia on a functional study, and
underwent successful coronary revascularization. In follow-up, 10 (43%) of
the 23 patients received ICD shocks (8 ± 8 per patient, range: 1-22) shocks)
and 9/10 had syncopelpresyncope associated with at least one ICD dis-
charge.
Follow-up (months)
Age Iyears)
Male gender
Mean left ventricular ejection fraction (%)
Previous history of a myocardial infarction
Presence of a left ventricular aneurysm
Q·wave infarction pattern on electrocardiogram
Sudden cardiac arrest presenting with exertion,
angina, or CPK elevation
Mean number of vessels with coronary disease
Mean severity of coronary stenosis (%)
Coronary revascularization considered complete
Ii-blocker therapy
Antiarrhythmic therapy
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Internal Atrial Defibrillation: Need for
Concomitant Pacemaker Therapy and Its Effect
on Pacemaker Function
Atul Prakash. Ryszard B. Krol, Irakli Giorgberidze, Philip Mathew, Luc Mongeon.
Nadeem Haque. Sankar Varanasi, Sanjeev Saksena. Eastern Heart Institute, Passaic &
UMDNJ Medical School, Newark, NJ
Implantable defibrillators are being considered as a therapeutic option for the
chronic management of atrial fibrillation (AF). The need for concomitant pace-
maker therapy and the effect on existing pacemaker function of internal atrial
defibrillation (lAD) shocks is unknown. 21 pts, mean age 67 ± 11 yrs, mean LA
diameter 43 ± 7 mm, mean LV ejection fraction 36.5 ± 15%, underwent lAD
for drug refractory AI' 7 pts had existing WIR pacemakers. Lead configura-
tions tested for lAD using a step up protocol were RV-RA. RV-SVC, RV-axillary
patch, RA-Ieft pulmonary artery (LPA) or RA-coronary sinus (CS). RA-LPA or
CS were preferred for pts with pacemakers. Results; Of 178 biphasic shocks
delivered with energies of 1 to 20J, 36 were successful in cardioverting AF
and these were analyzed. R-R interval preceding the successful shock ranged
from 200 to 1000 ms. Mean time to the first post shock ORS was 1076 ± 368
ms (vs mean proshock R-R interval of 780 ± 18 ms, p = 0.005) and the mean
first sinus cycle length of 168 ± 490 ms (vs 780 ± 18 ms preshock R-R inter-
val. p < 0.005). Significant post shock bradycardias occurred in 6 pts (28%). 1
pt had sinus arrest with third degree AV block lasting for 7.5s. 2 pts had third
degree AV block requiring ventricular pacing support. 3 pts had post shock
pauses >2s with 1 pt having a persistent sinus cycle of 2.5s for 6s. There
was no correlation between energy used, lead configurations and the inci-
dence of bradycardias. The 7 pts with existing WIR pacemakers were suc-
cessfullycardioverted using the RA-LPA orCS configuration at a mean energy
of 9.81 ± 8.6J. There was no effect of lAD using the RA-LPA or CS configura-
tion on pacemaker function. Conclusions; 1. Pts undergoing lAD may have a
transient bradycardia following successful cardioversion which may require
backup concomitant ventricular pacing. 2. lAD can be performed safely in pts
with existing pacemakers using RA-LPA or CS lead configurations without
affecting pacemaker function at the energy levels tested. 3. An implantable
atrial defibrillator should incorporate concomitant ventricular pacing
support.
1927-351
JACC February 1995 ABSTRACfS lIlA
implantation of a transvenous lead system. 20 echocardiography was there-
fore performed in 46 pts who underwent implantation of a transvenous lead
system. Fifteen pts were excluded because of inadequate 20 images. Re-
sults;
LV Volume (ml)
LV Mass (g)
Posterior Wall Thickness Imm}
Septal Thickness Imml
Enddlastolic LV Diameter Imm)
OFT IJ) >25 In = 22)
359 ± 72
229 ± 52
0.87 ± 0.19
1.64 ± 2.33
5.56 ± 1.96
OFT (J) ,025 In = 9)
263 ± 88
214 ± 51
0.94 ± 0.17
1.17 ± 1.32
6.14 ± 0.92
P
002
NS
NS
NS
NS
and not more than 1 in most cases.
ORS duration in V2 was 110 msec or more in 29 pts (76%) and 100-<11 0
msec in 9 pts. T wave inversions in VI-V3 could be found in 7 pts (18%) and
in Vl->V3 in 18 pts (47%) in ARVO and in V4-V6 in 3 pts with idiopathic right
ventricular arrhythmia.
Conclusions; Localised right precordial ORS prolongation is the ECG cri-
terium of highest sensitivity (93%) and outstanding specifity (1 00%) in ARVO
in adefinition using ORS duration ratios of right and left precordial leads. With
this criterium which cannot be found in idiopathic right ventricular arrhyth-
mia conventional ECG contributes significantly in the clinical definition of
ARVO.
Albert A. Hagege, Joseph Heller, Bruno Besse, Michel Desnos, Claude Guero\.
Boucicaut Hospital, Paris, France
In addition, age and LV ejection fraction were not significantly different be-
tween the 2 groups. All pts with OFT >25 J but only 28% of pts with OFT ::::25
J had an LV volume >275 ml (P < 0.011.
Conclusions; All pts with an LV volume <275 ml had acceptable OFTs.
These results suggest that LV volume is an important determinant of success-
ful defibrillation with transvenous lead systems since it may in part determine
transmyocardial current density for a given defibrillation shock.
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Electrocardiographic Criteria for Left Ventricular
Hypertrophy in Black PopUlation
HC
49/86
62/44
Criteria Comell p Adjusted p Cornell p vs
Voltage Cornell Product Cornell Voltage
LVH-BSA 45%.. 24% 52%
LVH-HT 35% ns 33% ns 43%
LVH-27 36% ns 29% 39% ns
Electrocardiographic Identification of Left
Ventricular Hypertrophy: Test Performance and
Variability in Relation to Definition of Hypertrophy
Peter M. Okin, Mary J. Roman, Richard B. Devereux, Paul Kligfield. Cornell Medical
Cente" New York, NY
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'p < 005, "p < 0.001
Comparison of overall performance using receiver operating characteris-
tic curves confirmed the superior overall performance of the Cornell product
relative to adjusted Cornell voltage for LVH-BSA and LVH-27. Further, the co-
efficient of variability of overall performance as a function of LVH definition
was greater for adjusted Cornell voltage (5.8%) than for the Cornell product
(1.5%). These data demonstrate that performance of ECG criteria for LVH will
vary with the definition of LVH and suggest that the Cornell product provides
the best overall accuracy and least variability between LVH definitions. These
findings have important implications forthe use of both ECG and echocardio-
graphic criteria for LVH in epidemiologic studies.
Test performance of the ECG for the detection of left ventricular hypertrophy
(LVH) will vary with the ECG criteria used, but may also vary with how LVH is
defined. LVH has been most commonly defined echocardiographically using
LV mass indexed to body surface area (LVH-BSA). but LVH has also been de-
fined using LV mass indexed to height (LVH-HTI. and more recently, tothe 2.7
power of height (LVH-27). To assess the relationship of test performance of
ECG criteria to the definition of LVH, simple Cornell voltage criteria, the prod-
uct of QRS duration and Cornell voltage (the Cornell product), and the Fram-
ingham adjusted Cornell voltage (using gender-specific regression equations
incorporating age and body mass index) were examined in 212 patients. Sen-
sitivity of each criterion for each definition of LVH was compared at matched
specificity of 95%:
SenlSpec
PPV/NPV
Anekwe Onwuanyi, Sanjiv Singai, Olujide Lawai, Faud Sharif, Manuel Cruz,
Matthews Hurley, Eric Vanderbush, David Hodges, Charles Francis. Harlem
Hospital Cente" Columbia University, New York, NY
The electrocardiographic (ECG) criteria for left ventricular hypertrophy {LVHI
i.e.. Romhilt-Estes (RE) score, Sokolow and Lyon (SL) and Cornell (C) have
poor sensitivity in blacks necessitating the development of race-specific ECG
criteria for LVH. Therefore, we studied 225 consecutive black patients (pts)
requiring echocardiograms in orderto develop a race-specific ECG criteria for
LVH. Eighty ECG variables were tested. LVH was defined by left ventricular
mass index (LVMI) ~131 g/m 2 in men or ~11 ag/m2 in women. There were
equal number of men and women with a mean age of 57.6 ± 15.4. Using uni-
variate and multivariate analysis, four ECG variables and their cut-off points
(i.e.. amplitude of R wave in L3 ~0.2 mV, amplitude of S wave in V3 ~ 1.5 mY,
ST depression in V6 ~0.1 mV, negative P wave in V1 ~0.1 mY) were identified
that best fit the model for LVH. A 14 pointscore system was derived using the
beta coefficient for each of the categorical variables. Comparison with estab-
lished criteria was as follows:
HC-Harlem Criteria, PPV-Positive Predictive Value, NPV-Negative Predictive
Value.
We conclude that race-specific ECG criteria does not improve beyond es-
tablished ECG standards for LVH detection. These data confirm that the ECG
remains a poor screening tool for LVH in blacks.
"Crochetage" in the R Wave in Inferior Leads: A
New Independant ECG Hallmark of Atrial Septal
Defect (ASD) Related to Shunt Severity
Right and Left Precordial QRS Duration Ratio in
Arrhythmogenic Right Ventricular Dysplasia
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Electrocardiographic Patterns/Generation of
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Prolongation of ORS duration in V2 of 110 msec or more seems to be a
specific diagnostic parameter in arrhythmogenic right ventricular dysplasia
(ARVO) with a sensitivity of 75%. In orderto define a more common criterium
with higher sensitiVity ORS duration in a best available limb lead and in all pre-
cordial leads were analysed in 41 pts. with ARVO fulfilling major and minor
diagnostic criteria and in 24 pts. with idiopathic right ventricular arrhythmia.
Localised right precordial prolongation of ORS duration could be achieved
in 38 pts (93%) with a ORS duration ratio in V2N4 and a ratio of the sum of
right (Vl-3) and left precordial (V4-6) ORS duration of > 1.1; on the contrary,
in all pts. with idiopathic right ventricular arrhythmia these ratios were <1.1
A rapid up and down motion ("crochetage") of the R ware in at least one in-
ferior lead - involVing the initial 30 to 70 msec of the ORS - is usually ob-
served in pts with ostium secundum (OS) ASO, but its diagnostic value was
not previously studied. Thus, we retrospectively tested the presence of a
"crochetage" in 2 groups (Gr) of pts: Gr 1 (568 pts with OS ASO and ORS
duration lesser than 120 msec); Gr 2 (459 pts with normal heart, matched for
age with Gr 1). In Gr 1, an incomplete right bundle branch block (RBBB) was
present in 522 pts, mean pulmonary artery pressure (PAP) and shunt severity
(Op/Os) were assessed in all pts, and surgery was performed in 484 pts. Re-
sults; (1) In Gr 1, a "crochetage" was absent in 143 pts (Gr A, 27%), present
in one inferior lead in 80 pts (Gr B, 15%) and in 2 to 3 leads in 309 pts (Gr C,
58%); (2) Sensitivity, specificity, accuracy and positive predictive value (PPV)
of a "crochetage" pattern for an OS ASO reached 73%, 93%, 92% and 94%;
comparatively, they reached 98%, 89%, 94% and 91 % for a RBBB pattern;
when associated to an incomplete RBBB, the PPVof a "crochetage" pattern
reaches 96% if limited to one lead and 99.5% if present in 2 to 3 inferior leads;
(2) In Gr 1, age and PAP were not different between Gr A, B or C; means Op/Os
were 2.8 in Gr A, 3.6 in Gr Band 3.8 in Gr C(p < 0.0001); in pts with pulmonary
hypertension (PAP> 30 mmHgl. this pattern was present in 213 leads in 29%
of cases if Op/Os < 1.5 vs 67% if Op/Os > 1.5 (p < 0.02); among pts oper-
ated on, this pattern was more frequent in case of larger defect (p < 0.0001);
using multiple regression analysis, only Op/Os and defect size were signifi-
cantly associated to this pattern (p < 0.0001); (4) After surgery, this pattern
rapidly «15 days) and frequently (37%) disappears while the RBBB pattern
persists. Conclusions; A "crochetage" olthe R ware in inferior leads is a new
ECG hallmark of ASO related to shunt size but not to the RBBB or PAP Associ-
ated to an incomplete RBBB, the PPVof this pattern for ASO reached almost
100%.
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